propaneheatersinfo.com

In a fascinating broadcast on National Public Radio, internationally renowned medicinal mushroom expert Paul Stamets tells his story of discovering the medicinal potential of agarikon, an extremely rare and threatened species of wood conk that requires century-old trees to grow. Agarikon is today all but extinct in Europe, its remaining distribution limited to the old growth forests on the North American West Coast.

Scientists have known for some time that mushrooms are not plants. Far from it. They are more closely related to animals and humans then they are to the vegetables we eat. Because of that, they are often at risk from the same bacteria and other “bugs” that cause diseases in humans. Being well aware of this fact, Stamets asked himself how agarikon – a perennial mushroom living for up to 50 years – managed to fight off diseases so well in the perpetually wet rainforests. It must possess a potent immune system, he concluded, with potential anti-bacterial and anti-viral compounds that may act as antibiotics for humans.

Stamets describes the agarikon conk as looking like a bee hive when viewed from the ground. Remember, they grow on the trunks of ancient tree giants, sometimes high up. (Use the agarikon-link on this page to view a picture of Paul Stamets holding an agarikon mushroom.) Please be aware that this is a threatened species and should be left alone in most cases. Just get out your digital camera if you are lucky enough to find a specimen. (Otherwise, no one may believe you.)

Using a proprietary extraction method on his organically cultivated agarikon, Stamets created an agarikon medicinal. He sent a sample of it to the Defense Department for testing within the BIO Shield Program, at a top security lab facility in Ft. Dietrich, Maryland. The BIO Shield Program is dedicated to finding remedies for use against bioterrorism threats and potential biological warfare agents, such as anthrax or smallpox.

Within this BIO Shield Program, tens of thousands of natural and manmade compounds have been tested for use against biological warfare pathogens. Drug discovery supervisor John Seacrest was happy to report on the radio show that the agarikon extract provided by Stamets had indeed been one of the few substances tested that had proved effective against smallpox related viruses.

Paul Stamets has since applied for a patent on a mushroom-based anti-viral drug. Boston investor John Norris is one of his financial backers. Mr. Norris believes in the project due in part to the fact that some individuals simply are not willing or not able to be vaccinated against smallpox or other potential biological warfare agents.

It’s also worth mentioning that Mr. Norris is a former second in command in the FDA hierarchy, and he believes that through his joint venture with Paul Stamets, they could soon be selling several hundred million doses of the Stamets agarikon extract to the armies of the United States, U.K., and Germany.

That may still be a few years into the future, though. Paul Stamets new mushroom related anti-viral medicine first has to stand up to exhaustive testing, and then eventually be approved for release by the FDA.

Note: The above article is intended for informational purposes only. Agarikon has not been approved by the FDA for use as a medicinal. Never use any herbal or mushroom-product for medicinal purposes unless advice to do so by a licensed medical practitioner.

Reference: NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms by Tom Banse, August 4, 2005.

About the author: Dr. Rafael has worked in natural health since the mid-90’s, specializing in medicinal mushrooms. Click Agarikon Mushrooms for agarikon-photo, mushroom products, free mushroom articles, or to request a unique copy of any mushroom article for your own web-site or magazine / ezine. Click Fomitopsis medicinal for scientific references about agarikon.